Aktualne aktualizacje dla Beijing Centergate [000931.SZ]

Beijing Centergate Technologies (holding) Co., Ltd. engages in the pharmaceutical production and sales, construction, real estate development, and property management businesses in China and internationally. The company offers huasu west-ground iodine, fesser phenylcycline hydrochloride, bosu fuma acid bisolol, yuanji beni flat hydrochloric acid, naloxone hydrochloride, five plus biochemical, and aramol quramado tablets and capsules. It also provides mucous membrane repair and oral health care products, including toothpaste, mouthwash, spray, dental equipment, and other oral care products for ulcers, burns, mechanical damage, and postoperative repair; and fruit enzymes, imported fungella enzymes, functional probiotics, and soda and other edible grade raw materials. In addition, the company invests in software technology, communications and electronic engineering, biomedicine, and life sciences and other fields. Beijing Centergate Technologies (holding) Co., Ltd. was founded in 1999 and is based in Beijing, China.